Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (unaudited)

v3.21.1
Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
3 Months Ended
Apr. 03, 2021
Mar. 28, 2020
Cash flows from operating activities:    
Net income (loss) $ 22,587 $ (17,223)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 15,237 8,376
Goodwill impairment   31,871
Stock-based compensation expense 2,107 1,533
Amortization of debt issuance costs 125 179
Benefit for deferred income taxes (906) (1,186)
Forward contract gains, net (2,402) (440)
Other, net 32 160
(Increase) decrease in:    
Accounts receivable (28,051) (6,838)
Inventories (10,809) (2,818)
Income taxes receivable 565 1,415
Other current assets (2,614) (2,740)
Other assets 2,139 1,213
Increase (decrease) in:    
Accounts payable 13,912 3,867
Accrued expenses and other liabilities (2,147) (4,652)
Income taxes payable 6,126 3,051
Other noncurrent liabilities (819) (701)
Net cash provided by operating activities 15,082 15,067
Cash flows from investing activities:    
Acquisition of a business, net of cash acquired (1,000)  
Amounts paid for net assets acquired (2,400)  
Capital expenditures (5,036) (2,937)
Proceeds from dispositions of equipment 35 3
Cash settlement of forward contracts 1,544 1,634
Software development costs (623)  
Net cash used in investing activities (7,480) (1,300)
Cash flows from financing activities:    
Borrowings on revolving credit facilities 6,602 2,000
Repayment of borrowings on revolving credit facilities (8,500) (5,500)
Repayment of borrowings on long-term non-revolving debt (4,029) (2,100)
Proceeds from stock issued 333 355
Dividends to shareholders (2,891) (2,885)
Other financing activities (974) (815)
Net cash used in financing activities (9,459) (8,945)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 2,565 310
Net increase in cash, cash equivalents and restricted cash 708 5,132
Cash, cash equivalents and restricted cash, beginning of period 25,257 22,162
Cash, cash equivalents and restricted cash, end of period $ 25,965 $ 27,294